AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

DAPAGLIFLOZIN in Zimbabwe

12 products registered with MCAZ β€” 12 active

Brand / ProductReg. No.HolderStatusExpires
NONE
TABLET, COATED; ORAL
2026/17.7/7402PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactive20 Apr 2031
SKY PHARM DAPA 5MG
TABLET, COATED; ORAL
2025/17.7/6968ADVENTURA INVESTMENTS LTDactive23 May 2030
DAPAGLIFLOZIN 10 COSPHARM
TABLET, COATED; ORAL
2025/17.7/6868COSPHARM INVESTMESTS PVT LTDactive13 Feb 2030
DAPAGLIFLOZIN 5 COSPHARM
TABLET, COATED; ORAL
2025/17.7/6867COSPHARM INVESTMENTS PVT LTDactive13 Feb 2030
GLYDA 5
TABLET, COATED; ORAL
2025/17.7/6824HETERO LABS LTDactive16 Jan 2030
GLYDA 10
TABLET, COATED; ORAL
2025/17.7/6825HETERO LABS LTDactive16 Jan 2030
SKY PHARMA DAPA 10MG
TABLET, COATED; ORAL
2025/17.7/6810ADVENTURA INVESTMENTS LTDactive10 Jan 2030
DEXIGLOFOZIN
TABLET, COATED; ORAL
2024/17.7/6670ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIESactive18 Jul 2029
AVAXIGA 5
TABLET, COATED; ORAL
2024/17.7/6730INNOVATA PHARMACEUTICALSactive31 Dec 2027
DAPAONE 10
TABLET, COATED; ORAL
2024/17.7/6661MSN LABORATORIES LTDactive31 Dec 2027
AVAXIGA 10
TABLET, COATED; ORAL
2024/17.7/6731INNOVATA PHARMACEUTICALSactive31 Dec 2027
DAPAONE 5
TABLET, COATED; ORAL
2024/17.7/6660MSN LABORATORIES PRIVATE LIMITEDactive31 Dec 2027

DAPAGLIFLOZIN β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 12 registered products containing DAPAGLIFLOZIN, of which 12 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track DAPAGLIFLOZIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Dapagliflozin β€” Zimbabwe (MCAZ) | AfricaRegulatory